Some endocrine aspects of affective disorders

Area of Science:

• Neuroendocrinology
• Psychiatry
• Endocrinology

Background:

• Depression is common, and while severe hypothyroidism can cause it, most depressed individuals are euthyroid.
• A robust hypothalamic-pituitary-thyroid (HPT) axis is linked to better depression recovery.
• Thyroid hormones can augment antidepressant efficacy and overcome treatment resistance.

Purpose of the Study:

• To explore the role of thyroid hormones and the HPT axis in depression.
• To evaluate the therapeutic potential of thyroid hormones and thyrotropin-releasing hormone (TRH).
• To assess the diagnostic utility of the TRH stimulation test in psychiatric populations.

Main Methods:

• Review of existing evidence on thyroid function and depression.
• Analysis of studies using thyroid hormones as adjuncts to antidepressant therapy.
• Evaluation of TRH stimulation tests in depressed and alcoholic patients.

Main Results:

• Thyroid hormones accelerate antidepressant action and remedy treatment failure, particularly with tricyclic antidepressants (TCAs).
• TRH shows mood-elevating properties but is not yet a viable therapeutic agent.
• The TRH test identified subpopulations of depressed and alcoholic patients with blunted TSH responses, unexplained by other endocrine issues.

Conclusions:

• Thyroid hormone supplementation can be a valuable strategy in managing depression, especially in treatment-resistant cases.
• The TRH stimulation test serves as a crucial psychoendocrine diagnostic tool for identifying specific patient subgroups.
• Further research is needed to fully harness the therapeutic potential of TRH and thyroid hormones in psychiatric disorders.